Cambridge Biotech Corp. infectious diseases/aids, cancer, diagnostics/imaging news

The Bankruptcy Appellate Panel for the First Circuit issued a temporary 21-day stay pending appeal of a U.S. Bankruptcy Court's order confirming CBCXQ's reorganization plan (see BioCentury July 22). The stay was requested by Institut Pasteur and Pasteur Sanofi Diagnostics. The appeals object to CBCXQ's assumption of various patent licenses owned by Institut Pasteur and Pasteur Sanofi Diagnostics and licensed to CBCXQ. ...